Insights

After a 3000 per cent share price surge on the back of an announcement with Samsung that piqued the ASX's interest, Alex Gluyas speaks with the Chief Executive of Etherstack, David Deacon, to see what all the fuss is about.

In part two of her three-part series on SMSF compliance, Lisa Papachristoforos runs through what information and documentation need to be provided to prepare an SMSF financials and tax return.

Performance rarely lasts, but small fee reductions can add materially to your retirement savings.

Steve Sammartino explains the existence of the 'Dichotomy Economy' – whereby the majority of attention and revenue now reside at the extreme ends of the market and the traditionally defensive middle ground has been eroded.

Patrick Duke outlines the recent SMSF regulatory and legislative changes and how they will impact your superannuation fund going forward.

The COVID-19 pandemic is not just influencing our lives today. It could impact our finances for many years to come.

Alex Gluyas explains how the acceleration in online shopping and working from home have allowed industrial property to break away from its struggling retail and office space counterparts.

Former deputy governor of the Reserve Bank of Australia and current non-resident fellow of the Lowy Institute, Stephen Grenville, takes us back to the catalyst of MMT's push towards mainstream economics in the GFC and explains how the COVID-19 crisis has given this radical rethink of economics a huge boost in popularity.

InvestSMART Capped Fee Portfolio quarterly updates for June

Investment markets may be unpredictable but one thing is for sure - each year seems to go by faster.

Everyone needs a knowledge refresher now and then. Our new course builds a solid foundation for better returns.

Alex Gluyas catches up with the CEO and Managing Director of Dimerix Limited, Nina Webster, to discuss its DMX-200 drug candidate which can be used to treat acute respiratory distress syndrome in COVID-19 patients and has recently been included in the REMAP-CAP study, a pandemic special study endorsed by the WHO.

Theo Marinis runs through three simple tests to use when figuring out if a financial planner is willing to go the distance for you.

It's a sell-off special this week with directors in charge of some well-performing ASX200 companies deciding to lock in their gains.

Steve Sammartino explains why investors need to be looking at new forms of abundance and scarcity, as these themes combined historically result in 'corporate heroes'.

Alex Gluyas speaks with the Managing Director of Brickworks, Lindsay Partridge, about the increasing demand for industrial property and warehouse facilities, how COVID has impacted its Building Products arm in the US and how its large position in Washington H Soul Pattinson allows it to consistently pay out a dividend.